Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference54 articles.
1. Current and future strategies for the treatment of malignant brain tumors;MG Castro;Pharmacol Ther,2003
2. Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations;RE Merchant;J Neurooncol,1990
3. Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma;M Farkkila;Br J Cancer,1994
4. Systemic gamma-interferon therapy for recurrent gliomas;MS Mahaley Jr;J Neurosurg,1988
5. Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients;A Boiardi;Cancer Immunol Immunother,1994
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Role of γδ T-Lymphocytes in Glioblastoma: Current Trends and Future Directions;Cancers;2023-12-10
2. γδ T cells: origin and fate, subsets, diseases and immunotherapy;Signal Transduction and Targeted Therapy;2023-11-22
3. γδ T cells as a potential therapeutic agent for glioblastoma;Frontiers in Immunology;2023-10-20
4. Human gamma-delta (γδ) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy;Cancer Letters;2023-09
5. Classification and function of γδT cells and its research progress in anti-glioblastoma;Discover Oncology;2023-08-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3